Form 8-K - Current report:
SEC Accession No. 0001725160-25-000082
Filing Date
2025-04-28
Accepted
2025-04-28 06:02:15
Documents
22
Period of Report
2025-04-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zntl-20250427.htm   iXBRL 8-K 37342
2 EX-99.1 a991kimetal_lossofrb1fun.htm EX-99.1 13956
3 EX-99.2 a992jeongetal_molecularr.htm EX-99.2 14060
4 EX-99.3 a993liuetal_azenomodelsi.htm EX-99.3 23265
5 EX-99.4 a994jamesonetal_azenoenc.htm EX-99.4 18989
10 a991kimetal_lossofrb1fun001.jpg GRAPHIC 2578875
11 a992jeongetal_molecularr001.jpg GRAPHIC 2387217
12 a993liuetal_azenomodelsi001.jpg GRAPHIC 3253849
13 a994jamesonetal_azenoenc001.jpg GRAPHIC 2938728
  Complete submission text file 0001725160-25-000082.txt   15655351

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20250427.xsd EX-101.SCH 2039
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20250427_def.xml EX-101.DEF 4226
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20250427_lab.xml EX-101.LAB 24316
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20250427_pre.xml EX-101.PRE 16232
24 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20250427_htm.xml XML 2958
Mailing Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121 (858) 263-4333
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

EIN.: 823607803 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39263 | Film No.: 25875818
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)